Sai Life Sciences Current Share Price | Sai Life Sciences Stock Screener
SAILIFE
Pharmaceuticals
Sai Life Sciences Current Stock Price Today
Live Share Price NSE
₹1600.50
▲
54.80 (3.55%)
Live Share Price BSE
₹1600.95
▲
53.95 (3.49%)
As of September 18, 2026, the live Sai Life Sciences share price (NSE: SAILIFE) is ₹1,600.50 on NSE and ₹1,600.95 on BSE, up 3.55% from the previous close, with shares trading between ₹1,550.30 and ₹1,613.90 in today's trading session, and a 52-week range of ₹795.00–₹1,675.40.
Browse SAILIFE complete financial statements to support your investment research.
Use the Sai Life Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sai Life Sciences Market Cap
₹32,697.61 Cr.
SAILIFE P/E Ratio (TTM)
93.08
Sai Life Sciences P/B Ratio
13.62
EPS (TTM)
₹16.43
Dividend Yield
-
Debt to Equity
0.14
SAILIFE 52 Week High
₹1675.40
Sai Life Sciences 52 Week Low
₹795.00
Operating Margin
29.00%
Profit Margin
16.83%
SAILIFE Revenue (TTM)
₹618.00
EBITDA
₹192.00
Net Income
₹104.00
Total Assets
₹3,626.00
Total Equity
₹2,484.00
Sai Life Sciences Current Share Price Chart
Track the current Sai Life Sciences share price and stock price with an interactive chart. Analyse SAILIFE price trends, trading volume, historical performance, and volatility across different timeframes — the complete Sai Life Sciences stock quote in one place.
Sai Life Sciences Company Profile - Fundamental Screener
Screen Sai Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SAILIFE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE570L01029
Sai Life Sciences Balance Sheet Screener
Screen SAILIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 3,626 | 3,160 | 2,275 | 2,187 | 2,157 | 1,817 | 1,410 | 1,216 |
| Current Assets | 1,411 | 1,505 | 945 | 964 | 944 | 804 | 613 | 691 |
| Fixed Assets | 1,815 | 1,488 | 1,180 | 1,037 | 751 | 701 | 641 | 374 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 309 | 299 | 560 | 540 | 565 | 356 | 149 | 160 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 2,484 | 2,128 | 975 | 888 | 879 | 863 | 794 | 720 |
| Share Capital | 21 | 21 | 18 | 18 | 18 | 18 | 16 | 16 |
| Reserves & Surplus | 2,463 | 2,108 | 957 | 870 | 861 | 845 | 777 | 703 |
Sai Life Sciences Income Statement Screener - Profit & Revenue Analysis
Screen Sai Life Sciences income statement and profit fundamentals.
Analyze SAILIFE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sai Life Sciences share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 618 | 558 | 589 | 506 | 553 | 565 | 443 | 288 | 406 | 449 | 395 |
| Expenses | 426 | 406 | 422 | 376 | 392 | 377 | 315 | 254 | 293 | 320 | 287 |
| EBITDA | 192 | 152 | 167 | 131 | 161 | 188 | 128 | 34 | 112 | 129 | 108 |
| Operating Profit % | 29.00% | 27.00% | 27.00% | 24.00% | 27.00% | 32.00% | 28.00% | 9.00% | 26.00% | 27.00% | 25.00% |
| Depreciation | 45 | 46 | 38 | 38 | 40 | 44 | 31 | 31 | 36 | 34 | 31 |
| Interest | 8 | 8 | 11 | 12 | 9 | 10 | 21 | 21 | 21 | 23 | 23 |
| Profit Before Tax | 139 | 98 | 119 | 81 | 112 | 134 | 76 | -18 | 55 | 72 | 53 |
| Tax | 35 | 25 | 31 | 20 | 28 | 34 | 20 | -5 | 14 | 18 | 13 |
| Net Profit | 104 | 73 | 88 | 61 | 84 | 100 | 56 | -14 | 42 | 54 | 40 |
| EPS | 4.93 | 3.46 | 4.24 | 2.90 | 4.01 | 4.77 | 31.00 | -0.74 | 2.22 | 2.89 | 2.19 |
Sai Life Sciences Cash Flow Screener - Liquidity Fundamentals
Screen SAILIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 509 | 314 | 263 | 219 | 105 | -36 | 116 | 129 |
| Investing Activities | -395 | -536 | -191 | -99 | -102 | -260 | -262 | -158 |
| Financing Activities | -124 | 301 | -95 | -201 | 72 | 296 | -4 | 268 |
| Net Cash Flow | -9 | 79 | -24 | -80 | 75 | -1 | -150 | 239 |
Sai Life Sciences Shareholding Pattern Screener
See Sai Life Sciences shareholding pattern with promoter, FII, and DII holdings.
Check Sai Life Sciences promoter holding and ownership changes for SAILIFE on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Jul | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 34.61% | 34.53% | 35.17% | 35.15% | 34.94% | 34.70% | 39.64% | 35.24% |
| FII Holding | 21.17% | 19.65% | 12.36% | 14.58% | 22.50% | 21.40% | 0.00% | 7.64% |
| DII Holding | 31.54% | 32.71% | 13.26% | 21.64% | 29.91% | 31.41% | 0.00% | 5.61% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.13% | 6.78% | 7.69% | 6.56% | 7.91% | 5.95% | 0.00% | 18.68% |
| Other Holding | 6.56% | 6.33% | 31.52% | 22.07% | 4.74% | 6.54% | 60.36% | 32.84% |
| Shareholder Count | 117,527 | 125,096 | 140,677 | 126,380 | 119,705 | 114,820 | 70 | 572,970 |
Sai Life Sciences Share Dividend Screener - Share Yield Analysis
Check Sai Life Sciences dividend history with payout and yield data.
View Sai Life Sciences dividend details including ex-dates and amounts for SAILIFE stock.
Sai Life Sciences Stock Index Membership
See which indices include Sai Life Sciences stock.
Check SAILIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX BSEIPO
BSE INDEX SMLCAP
NIFTY 500
NIFTY IPO
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP
Sai Life Sciences Market Events Screener - Corporate Actions
Get Sai Life Sciences corporate actions including splits, bonuses, and buybacks.
Check Sai Life Sciences stock events that may affect SAILIFE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-17 | 2026-09-17 | Annual General Meeting | NA | 8.77% |
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | 12.96% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | 13.13% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 0.21% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | 3.40% |
| 2025-09-11 | 2025-09-11 | Annual General Meeting | NA | 8.86% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -2.74% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | -0.61% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | -0.14% |
Sai Life Sciences Competitors Screener - Peer Comparison
Screen SAILIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 440,278 | 36.48 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 244,178 | 84.64 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 184,478 | 87.77 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,585 | 24.32 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,140 | 32.86 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 104,025 | 97.64 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,570 | 30.44 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,513 | 25.98 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 94,336 | 17.27 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 94,184 | 45.49 | 14,636 | 14.85% | 1,938 | 37.66 |
Sai Life Sciences Company Announcements - News Screener
Screen SAILIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-08-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-25 | Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-25 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-25 | Reg. 34 (1) Annual Report. | - |
| 2026-08-25 | Notice Of 27Th Annual General Meeting (AGM) Of The Company | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-24 | Information Relating To 27Th Annual General Meeting (AGM) And Cut-Off Date For E-Voting. | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-08-06 | Press Release For The Unaudited Financial Results For The Quarter Ended On June 30 2026 | - |
| 2026-08-06 | Considered And Approved Unaudited Financial Results For The Quarter Ended On 30 June 2026. | - |
| 2026-08-06 | Board Meeting Outcome for Considered And Approved The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended On 30 June 2026 | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |